The Influence of Anti-N-Acetyl-D-Glucosamine B cells on Type One Diabetes in Mice
抗N-乙酰-D-葡萄糖胺B细胞对小鼠一型糖尿病的影响
基本信息
- 批准号:8075993
- 负责人:
- 金额:$ 36.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcetylglucosamineAntibodiesAntibody FormationAntigen PresentationApoptosisAsthmaAutoimmune DiabetesAutoimmune DiseasesAutoimmune ProcessAutoimmune ResponsesB-Lymphocyte SubsetsB-LymphocytesBacteriaBindingBirthBlocking AntibodiesBlood GlucoseBlood VesselsCD4 Positive T LymphocytesCD8B1 geneCarbohydratesCell DeathCell SeparationCell WallCell physiologyCellsChildhoodChitinCommunicable DiseasesDataDefectDevelopmentDiabetes MellitusDiagnosisDiseaseEnzymesEpidemiologic StudiesEpitopesEventFamilyFrequenciesGeneticGlucosamineGoalsHumanImmuneImmune systemImmunizationImmunofluorescence ImmunologicIn SituInbred NOD MiceIncidenceIndividualInfectionInfectious AgentInsulinInsulin-Dependent Diabetes MellitusIslets of LangerhansKnowledgeLifeLymphocyteMammalian CellMediatingModelingModificationMonitorMouse StrainsMusN-terminalNecrosisNeonatalNeurologicNon obeseOrganismPancreasPhenotypePolymersPopulationPreventionPrevention strategyProcessProtein DynamicsProteinsResistanceRodent ModelRoleSSCP AnalysisScarlet FeverSeveritiesSimulateSocietiesSpecificityStagingStreptococcal InfectionsStreptococcal VaccinesStreptococcus pyogenesStressT-LymphocyteT-Lymphocyte EpitopesTestingTimeTo autoantigenTransgenic MiceVaccinationabstractingautoreactive T cellbaseblood glucose regulationcritical perioddiabetichumoral immunity deficiencyimprovedisletlymph nodesmouse developmentmouse modelpreventprotective effecttherapy development
项目摘要
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Manipulation of the glycan-specific natural antibody repertoire for immunotherapy.
- DOI:10.1111/imr.12397
- 发表时间:2016-03
- 期刊:
- 影响因子:8.7
- 作者:New JS;King RG;Kearney JF
- 通讯作者:Kearney JF
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Franklin Kearney其他文献
John Franklin Kearney的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Franklin Kearney', 18)}}的其他基金
Development and maintenance of human glycan and phospholipid antibody repertoires
人聚糖和磷脂抗体库的开发和维护
- 批准号:
10396001 - 财政年份:2019
- 资助金额:
$ 36.63万 - 项目类别:
Development and maintenance of human glycan and phospholipid antibody repertoires
人聚糖和磷脂抗体库的开发和维护
- 批准号:
10592416 - 财政年份:2019
- 资助金额:
$ 36.63万 - 项目类别:
Antibody induction by Group B streptococcal vaccines for protection against fungal infections
B 组链球菌疫苗诱导抗体以预防真菌感染
- 批准号:
9090867 - 财政年份:2016
- 资助金额:
$ 36.63万 - 项目类别:
Effects of neonatal microbial exposure on anti-polysaccharide B cell development
新生儿微生物暴露对抗多糖 B 细胞发育的影响
- 批准号:
10218018 - 财政年份:2012
- 资助金额:
$ 36.63万 - 项目类别:
Effects of neonatal microbial exposure on anti-polysaccharide B cell development
新生儿微生物暴露对抗多糖 B 细胞发育的影响
- 批准号:
8433271 - 财政年份:2012
- 资助金额:
$ 36.63万 - 项目类别:
Effects of neonatal microbial exposure on anti-polysaccharide B cell development
新生儿微生物暴露对抗多糖 B 细胞发育的影响
- 批准号:
9755324 - 财政年份:2012
- 资助金额:
$ 36.63万 - 项目类别:
Effects of neonatal microbial exposure on anti-polysaccharide B cell development
新生儿微生物暴露对抗多糖 B 细胞发育的影响
- 批准号:
8298425 - 财政年份:2012
- 资助金额:
$ 36.63万 - 项目类别:
Effects of neonatal microbial exposure on anti-polysaccharide B cell development
新生儿微生物暴露对抗多糖 B 细胞发育的影响
- 批准号:
8797294 - 财政年份:2012
- 资助金额:
$ 36.63万 - 项目类别:
Effects of neonatal microbial exposure on anti-polysaccharide B cell development
新生儿微生物暴露对抗多糖 B 细胞发育的影响
- 批准号:
8609548 - 财政年份:2012
- 资助金额:
$ 36.63万 - 项目类别:
Effects of neonatal microbial exposure on anti-polysaccharide B cell development
新生儿微生物暴露对抗多糖 B 细胞发育的影响
- 批准号:
9011989 - 财政年份:2012
- 资助金额:
$ 36.63万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 36.63万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 36.63万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 36.63万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 36.63万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别: